Table 3.
Post-EBRT toxicity and urinary stress incontinence (n=6)
| Toxicity | RTOG rating* | ||||
|---|---|---|---|---|---|
|
| |||||
| G1 | G2 | G3 | G4 | G5 | |
| At 1 year | |||||
| - Bladder | 2/6 (#6,#7) | 0 | 0 | 0 | 0 |
| - Bowel | 1/6 (#3) | 0 | 0 | 0 | 0 |
| At 2 years | |||||
| - Bladder | 1/6 (#7) | 1**/6 (#2) | 0 | 0 | |
| - Bowel | 1/6 (#3) | 0 | 0 | 0 | 0 |
|
| |||||
| Urinary incontinence | Stress Ingelman Sundberg score | ||||
|
| |||||
| 1 | 2 | 3 | |||
| - At 1 year | 1/6 (#7) | 0 | 0 | ||
| - At 2 years | 1/6 (#7) | 0 | 0 | ||
EBRT: external beam radiotherapy; RTOG: Radiation Therapy Oncology Group.
*
RTOG rating: Grade 1, minor symptoms requiring no treatment; Grade 2, outpatient management of symptoms: lifestyle (performance status) not affected; Grade 3, distressing symptoms altering patient’s lifestyle (performance status); hospitalization for diagnosis or minor surgical intervention (e.g., urethral dilatation) might be required; Grade 4, major surgical intervention (e.g., laparotomy, colectomy, or cystectomy) or prolonged hospitalization; Grade 5, fatal complication.
**
Radiation cystitis.